<DOC>
	<DOCNO>NCT01088698</DOCNO>
	<brief_summary>Golimumab , TNF-alpha antibody , approve EC USA treatment psoriatic arthritis . The aim study determine randomize half-side comparison whether additional narrowband UVB-311nm phototherapy accelerate improve clearance psoriatic skin lesion golimumab-treated patient .</brief_summary>
	<brief_title>Golimumab Plus UVB-311nm Psoriasis</brief_title>
	<detailed_description>Psoriatic skin lesion patient psoriatic arthritis receive standard treatment golimumab ( 50 mg 100 mg s.c. month depend total body weight whether 100 kg , respectively ) expose UVB-311nm phototherapy randomize body half ( left right ; head exempt ) 3 x per week six week and/or complete response ( define reduction PASI &lt; 3 ) . A patient qualify A ) golimumab start within week B ) 3 month golimumab treatment PASI reduction small 90 % . PASI score , patient visual analogue score ( VAS ) therapeutic response , patient VAS severity skin lesion assess weekly ; follow-up visit month 3 , 6 , 12 . The primary hypothesis phototherapy increase PASI reduction expose body site 20 % . Paired Wilcoxon test difference PASI patient VAS score do ; Fisher exact test apply determine difference complete remission , PASI reduction &gt; 90 % , &gt; 75 % and/or 50 % body sit .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Age &gt; 18 year Patients psoriatic arthritis receive treatment golimumab Patient wish treatment psoriatic skin lesion Pregnancy lactation Presence and/or history malignant melanoma Presence and/or history invasive squamous cell carcinoma skin Presence and/or history 3 basal cell carcinomas Dysplastic nevus syndrome Antinuclear antibody ( dsDNA , Ro/SSA , La/SSB ) Autoimmune disorder lupus erythematosus dermatomyositis Abnormal photosensitivity photosensitive disease porphyria , chronic actinic dermatitis , Xeroderma pigmentosum , basal cell nevus syndrome , others General poor health status</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>psoriasis</keyword>
	<keyword>golimumab</keyword>
	<keyword>TNF-alpha inhibition</keyword>
	<keyword>phototherapy</keyword>
	<keyword>311-nm</keyword>
</DOC>